Milagres L G, Gorla M C, Sacchi C T, Rodrigues M M
Bacteriology Division, Adolfo Lutz Institute, São Paulo, SP 01246-902, Brazil.
Infect Immun. 1998 Oct;66(10):4755-61. doi: 10.1128/IAI.66.10.4755-4761.1998.
Pre- and postvaccination serum samples from 77 children aged 2 to 6 years, who received the Cuban BC vaccine (B:4:P1.15), were analyzed for bactericidal antibodies against a local B:4:P1.15 strain (N44/89). Sera from 16 individuals with bactericidal antibodies against the B:4:P1.15 strain were tested against 23 Brazilian isolates. These include B:4 strains of distinct serosubtypes: P1.15, P1.7,1, P1.3, P1.9, P1.nt, and a B:8,19,23:P1.16 strain. A Cuban B:4:P1.15 strain (Cu385/83) was also included in the study. The specificities of bactericidal antibodies were analyzed by using mutant strains lacking a class 1 protein (PorA protein) or a class 5 protein or both. The results indicated that PorA and class 5 proteins are the main targets recognized by the bactericidal antibodies of vaccinees. Nonetheless, a complex pattern of recognition by bactericidal antibodies was found, and vaccinees were grouped according to antibody specificity. Antibodies from some individuals recognized PorA of serosubtype P1.15. However, antibodies from these individuals could not kill all P1.15 strains tested. Antibodies from a second group recognized both PorA and class 5 proteins, and antibodies from a third group recognized an as yet unidentified target antigen. The results demonstrate the importance of determining the fine epitope specificity of bactericidal antibodies to improve the existing vaccines against B meningococci.
对77名2至6岁接种古巴B群脑膜炎球菌疫苗(B:4:P1.15)的儿童接种疫苗前后的血清样本进行分析,检测其针对本地B:4:P1.15菌株(N44/89)的杀菌抗体。对16名具有针对B:4:P1.15菌株杀菌抗体的个体的血清进行检测,以对抗23株巴西分离株。这些分离株包括不同血清亚型的B:4菌株:P1.15、P1.7,1、P1.3、P1.9、P1.nt,以及一株B:8,19,23:P1.16菌株。研究中还包括一株古巴B:4:P1.15菌株(Cu385/83)。通过使用缺乏1类蛋白(PorA蛋白)或5类蛋白或两者的突变菌株来分析杀菌抗体的特异性。结果表明,PorA和5类蛋白是疫苗接种者杀菌抗体识别的主要靶点。尽管如此,发现杀菌抗体的识别模式复杂,且根据抗体特异性对疫苗接种者进行了分组。一些个体的抗体识别血清亚型P1.15的PorA。然而,这些个体的抗体不能杀死所有测试的P1.15菌株。第二组个体的抗体识别PorA和5类蛋白,第三组个体的抗体识别一种尚未确定的靶抗原。结果表明,确定杀菌抗体的精细表位特异性对于改进现有的抗B群脑膜炎球菌疫苗非常重要。